FDA approves first long-acting flea and tick preventative for dogs
Description
This past summer, the US Food and Drug Administration approved Bravecto® [brah-VECK-toe] Quantum, or fluralaner [FLEUR-ah-lah-ner] extended-release injectable suspension, for use in dogs and puppies over six months old. It’s the first long-acting flea and tick preventative for dogs. One injection protects dogs against fleas and ticks for eight to twelve months. The treatment interval depends on which species of ticks a dog is most likely to contact.
Bravecto® Quantum must be prescribed by a veterinarian. Fluralaner belongs to the isoxazoline [eye-socks-ah-ZO-lean] class of parasiticides, which are generally safe for dogs. However, some dogs may experience neurological adverse reactions after exposure to these products. That’s why pet parents should talk with their veterinarian to see if Bravecto® Quantum is right for their dog.
United States
